by Lance Smith | Mar 27, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Lambert Initiative facilitating supply for clinical trial A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with Tourette syndrome will be conducted by Wesley Medical Research, with the cannabis supply facilitated...by Lance Smith | Mar 27, 2019 | Study Scavenger Clinical Trial Recruitment Platform
New rules well balanced, focused on patient rights, safety and well-being Welcoming the New Drugs and Clinical Trial Rules, 2019 which were notified by the Ministry of Health & Family Welfare and made public on March 25th, the Indian Society for Clinical Research...by Lance Smith | Mar 27, 2019 | Study Scavenger Clinical Trial Recruitment Platform
HempMy Pet™ Announces a CSU Clinical Trials Study using their Hemp-derived CBD Oil to Manage Pain in Osteoarthritic Dogs, in Collaboration with Colorado State University College of Veterinary Medicine and Biomedical Sciences, and Downing Center for Pain Management...by Lance Smith | Mar 27, 2019 | Study Scavenger Clinical Trial Recruitment Platform
New Clinical Trial Adds to Growing Number of Studies Supporting Use of Signatera as a Potential Surrogate Endpoint Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, will partner with AMAL Therapeutics on a clinical trial focused on stage IV...by Lance Smith | Mar 27, 2019 | Study Scavenger Clinical Trial Recruitment Platform
dysfunction (ED). With this feedback, CURE anticipates submitting its IND application in preparation for multiple clinical trials starting in Q3 of 2019. “Receiving the FDA’s guidance is a key step toward executing our clinical development program,” said Rob Davidson,...by Lance Smith | Mar 27, 2019 | Study Scavenger Clinical Trial Recruitment Platform
– Investigational compound fezolinetant reduced frequency and severity of vasomotor symptoms in postmenopausal women – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced results from a...